BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21034635)

  • 1. Preventive effect of ulinastatin and gabexate mesylate on post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Zhang ZF; Yang N; Zhao G; Zhu L; Zhu Y; Wang LX
    Chin Med J (Engl); 2010 Sep; 123(18):2600-6. PubMed ID: 21034635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial.
    Ueki T; Otani K; Kawamoto K; Shimizu A; Fujimura N; Sakaguchi S; Matsui T
    J Gastroenterol; 2007 Feb; 42(2):161-7. PubMed ID: 17351806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
    Zheng M; Chen Y; Yang X; Li J; Zhang Y; Zeng Q
    BMC Gastroenterol; 2007 Feb; 7():6. PubMed ID: 17295917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproteases in preventing post-ERCP acute pancreatitis.
    Tsujino T; Kawabe T; Omata M
    JOP; 2007 Jul; 8(4 Suppl):509-17. PubMed ID: 17625308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of ulinastatin in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: the Emperor's New Clothes or Aladdin's Magic Lamp?
    Chen S; Shi H; Zou X; Luo H
    Pancreas; 2010 Nov; 39(8):1231-7. PubMed ID: 20531245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study.
    Fujishiro H; Adachi K; Imaoka T; Hashimoto T; Kohge N; Moriyama N; Suetsugu H; Kawashima K; Komazawa Y; Ishimura N; Ishihara S; Amano Y; Kinoshita Y
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1065-9. PubMed ID: 16724996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis.
    Andriulli A; Leandro G; Federici T; Ippolito A; Forlano R; Iacobellis A; Annese V
    Gastrointest Endosc; 2007 Apr; 65(4):624-32. PubMed ID: 17383459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between ulinastatin and nafamostat for prevention of post-endoscopic retrograde cholangiopancreatography complications: a prospective, randomized trial.
    Park JY; Jeon TJ; Hwang MW; Sinn DH; Oh TH; Shin WC; Choi WC
    Pancreatology; 2014; 14(4):263-7. PubMed ID: 25062874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of gabexate mesylate and ulinastatin for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Yoo YW; Cha SW; Kim A; Na SY; Lee YW; Kim SH; Lee HIe; Lee YJ; Yang HW; Jung SH
    Gut Liver; 2012 Apr; 6(2):256-61. PubMed ID: 22570757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia: A systematic review and meta-analysis.
    Wang G; Xiao G; Xu L; Qiu P; Li T; Wang X; Wen P; Wen J; Xiao X
    Pancreatology; 2018 Jun; 18(4):370-378. PubMed ID: 29550097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic ulinastatin administration for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: A meta-analysis.
    Zhu K; Wang JP; Su JG
    Exp Ther Med; 2017 Oct; 14(4):3036-3056. PubMed ID: 28966682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gabexate mesylate in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis update.
    Zheng MH; Bai JL; Meng MB; Chen YP
    Curr Ther Res Clin Exp; 2008 Aug; 69(4):288-304. PubMed ID: 24692807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of gabexate mesilate in preventing post endoscopic retrograde cholangiopancreatography pancreatitis: A meta-analysis of randomized clinical trials.
    Chiu YJ; Chen SC; Kang YN; Hou SK; Chao CC; Chang CC
    J Formos Med Assoc; 2021 Apr; 120(4):1090-1099. PubMed ID: 33183879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials.
    Rudin D; Kiss A; Wetz RV; Sottile VM
    J Gastroenterol Hepatol; 2007 Jul; 22(7):977-83. PubMed ID: 17559376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of prophylactic allopurinol use in post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Zheng M; Chen Y; Bai J; Xin Y; Pan X; Zhao L
    Pancreas; 2008 Oct; 37(3):247-53. PubMed ID: 18815544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
    Lyu Y; Cheng Y; Wang B; Xu Y; Du W
    BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant drugs to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: What does evidence suggest?
    Fuentes-Orozco C; Dávalos-Cobián C; García-Correa J; Ambriz-González G; Macías-Amezcua MD; García-Rentería J; Rendón-Félix J; Chávez-Tostado M; Cuesta-Márquez LA; Alvarez-Villaseñor AS; Cortés-Flores AO; González-Ojeda A
    World J Gastroenterol; 2015 Jun; 21(21):6745-53. PubMed ID: 26074713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-ERCP pancreatitis.
    Arata S; Takada T; Hirata K; Yoshida M; Mayumi T; Hirota M; Yokoe M; Hirota M; Kiriyama S; Sekimoto M; Amano H; Wada K; Kimura Y; Gabata T; Takeda K; Kataoka K; Ito T; Tanaka M
    J Hepatobiliary Pancreat Sci; 2010 Jan; 17(1):70-8. PubMed ID: 20012323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial.
    Yoo JW; Ryu JK; Lee SH; Woo SM; Park JK; Yoon WJ; Lee JK; Lee KH; Hwang JH; Kim YT; Yoon YB
    Pancreas; 2008 Nov; 37(4):366-70. PubMed ID: 18953247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic rectal indomethacin may be ineffective for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in general patients: A meta-analysis.
    Feng Y; Navaneethan U; Zhu X; Varadarajulu S; Schwartz I; Hawes R; Hasan M; Yang A
    Dig Endosc; 2017 May; 29(3):272-280. PubMed ID: 27914176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.